Interested in hearing what they say, here is the cc question we selected last week. We have had some updates since then.

Combo/BLA

BLA submission timeline with 525mg vs 700mg?
Anticipation date FDA will give final safety data requirements?
When will the 700mg safety data be complete?


Mono

Update on FDA meeting date?


TNBC

Recruiting status on the open TNBC site? Patients screened yet?
Any update on your investigation into the TNBC trial delays?
Updates on remaining sites opening? IRB approval for these yet?


Remaining (GvHD, Cancer, NASH, MS )

Status updates: GvHD enrollment, NASH study, any of the 8 cancer pre-clinical trials started, Colon Cancer IND, MS plans.


Financing / License Agreement / Partnerships:

Updates on Prognostic test license? Is this pending 510(k) FDA decision?
Updates on commercialization pharma company agreement related to HIV and GVHD? Or does CYDY expect to commercialize Leronlimab?
Terms discussed in non-binding term sheet that was verbally accepted pending BOD approval from China investment?
Any progression in Samsung capital investment?
Updates on mid-tier pharma partnership?


Other:

Impacts of Dr. Rae (Business Development) so far?
How does he plan to increase share price?
Expected release date for Dr. Sacha HIV/Leronlimab research results?

Read More: https://investorshangout.com/post/view?id=548...z5ugVVKHYQ